21 results on '"Wei, Ying"'
Search Results
2. Catestatin Inhibits Obesity-Induced Macrophage Infiltration and Inflammation in the Liver and Suppresses Hepatic Glucose Production, Leading to Improved Insulin Sensitivity.
- Author
-
Wei Ying, Mahata, Sumana, Bandyopadhyay, Gautam K., Zhenqi Zhou, Wollam, Joshua, Vu, Jessica, Mayoral, Rafael, Nai-Wen Chi, Webster, Nicholas J. G., Corti, Angelo, Mahata, Sushil K., Ying, Wei, Zhou, Zhenqi, and Chi, Nai-Wen
- Subjects
- *
MACROPHAGES , *INFLAMMATION prevention , *LIVER diseases , *INSULIN resistance , *OBESITY , *KUPFFER cells , *GLUCOSE metabolism , *ANIMAL experimentation , *COMPARATIVE studies , *GENES , *GENETIC disorders , *GLUCAGON , *HORMONES , *INFLAMMATION , *INSULIN , *LIPID metabolism disorders , *LIVER , *RESEARCH methodology , *MEDICAL cooperation , *METABOLISM , *MICE , *PEPTIDES , *PROTEIN precursors , *RESEARCH , *EVALUATION research - Abstract
The activation of Kupffer cells (KCs) and monocyte-derived recruited macrophages (McMΦs) in the liver contributes to obesity-induced insulin resistance and type 2 diabetes. Mice with diet-induced obesity (DIO mice) treated with chromogranin A peptide catestatin (CST) showed several positive results. These included decreased hepatic/plasma lipids and plasma insulin, diminished expression of gluconeogenic genes, attenuated expression of proinflammatory genes, increased expression of anti-inflammatory genes in McMΦs, and inhibition of the infiltration of McMΦs resulting in improvement of insulin sensitivity. Systemic CST knockout (CST-KO) mice on normal chow diet (NCD) ate more food, gained weight, and displayed elevated blood glucose and insulin levels. Supplementation of CST normalized glucose and insulin levels. To verify that the CST deficiency caused macrophages to be very proinflammatory in CST-KO NCD mice and produced glucose intolerance, we tested the effects of (sorted with FACS) F4/80+Ly6C- cells (representing KCs) and F4/80-Ly6C+ cells (representing McMΦs) on hepatic glucose production (HGP). Both basal HGP and glucagon-induced HGP were markedly increased in hepatocytes cocultured with KCs and McMΦs from NCD-fed CST-KO mice, and the effect was abrogated upon pretreatment of CST-KO macrophages with CST. Thus, we provide a novel mechanism of HGP suppression through CST-mediated inhibition of macrophage infiltration and function. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
3. Adipose tissue B2 cells promote insulin resistance through leukotriene LTB4/LTB4R1 signaling.
- Author
-
Wei Ying, Wollam, Joshua, Ofrecio, Jachelle M., Bandyopadhyay, Gautam, Ouarrat, Dalila El, Yun Sok Lee, Da Young Oh, Pingping Li, Osborn, Olivia, Olefsky, Jerrold M., Ying, Wei, El Ouarrat, Dalila, Lee, Yun Sok, Oh, Da Young, and Li, Pingping
- Subjects
- *
ADIPOSE tissues , *INSULIN resistance , *LEUKOTRIENES , *CELLULAR signal transduction , *CELLULAR immunity , *MACROPHAGES , *ANIMALS , *B cells , *CELL receptors , *FAT content of food , *MICE , *OBESITY , *T cells - Abstract
Tissue inflammation is a key component of obesity-induced insulin resistance, with a variety of immune cell types accumulating in adipose tissue. Here, we have demonstrated increased numbers of B2 lymphocytes in obese adipose tissue and have shown that high-fat diet-induced (HFD-induced) insulin resistance is mitigated in B cell-deficient (Bnull) mice. Adoptive transfer of adipose tissue B2 cells (ATB2) from wild-type HFD donor mice into HFD Bnull recipients completely restored the effect of HFD to induce insulin resistance. Recruitment and activation of ATB2 cells was mediated by signaling through the chemokine leukotriene B4 (LTB4) and its receptor LTB4R1. Furthermore, the adverse effects of ATB2 cells on glucose homeostasis were partially dependent upon T cells and macrophages. These results demonstrate the importance of ATB2 cells in obesity-induced insulin resistance and suggest that inhibition of the LTB4/LTB4R1 axis might be a useful approach for developing insulin-sensitizing therapeutics. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
4. MicroRNA-223 is a crucial mediator of PPARγ-regulated alternative macrophage activation.
- Author
-
Wei Ying, Tseng, Alexander, Cheng-An Chang, Richard, Morin, Andrew, Brehm, Tyler, Triff, Karen, Nair, Vijayalekshmi, Guoqing Zhuang, Hui Song, Srikanth Kanameni, Haiqing Wang, Golding, Michael C., Bazer, Fuller W., Chapkin, Robert S., Safe, Stephen, Beiyan Zhou, Ying, Wei, Chang, Richard Cheng-An, Zhuang, Guoqing, and Song, Hui
- Subjects
- *
RNA physiology , *ADIPOSE tissues , *ANIMAL experimentation , *ANIMALS , *BONE marrow , *CONNECTIVE tissue cells , *DIET , *FAT cells , *GENES , *IMMUNITY , *INFLAMMATION , *INSULIN resistance , *MICE , *GENETIC mutation , *PROTEINS , *RESEARCH funding , *RNA , *T cells , *TRANSCRIPTION factors , *THIAZOLIDINEDIONES , *GENE expression profiling , *PHARMACODYNAMICS - Abstract
Polarized activation of adipose tissue macrophages (ATMs) is crucial for maintaining adipose tissue function and mediating obesity-associated cardiovascular risk and metabolic abnormalities; however, the regulatory network of this key process is not well defined. Here, we identified a PPARγ/microRNA-223 (miR-223) regulatory axis that controls macrophage polarization by targeting distinct downstream genes to shift the cellular response to various stimuli. In BM-derived macrophages, PPARγ directly enhanced miR-223 expression upon exposure to Th2 stimuli. ChIP analysis, followed by enhancer reporter assays, revealed that this effect was mediated by PPARγ binding 3 PPARγ regulatory elements (PPREs) upstream of the pre-miR-223 coding region. Moreover, deletion of miR-223 impaired PPARγ-dependent macrophage alternative activation in cells cultured ex vivo and in mice fed a high-fat diet. We identified Rasa1 and Nfat5 as genuine miR-223 targets that are critical for PPARγ-dependent macrophage alternative activation, whereas the proinflammatory regulator Pknox1, which we reported previously, mediated miR-223-regulated macrophage classical activation. In summary, this study provides evidence to support the crucial role of a PPARγ/miR-223 regulatory axis in controlling macrophage polarization via distinct downstream target genes. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
5. Bu-Shen-Yi-Qi formulae suppress chronic airway inflammation and regulate Th17/Treg imbalance in the murine ovalbumin asthma model.
- Author
-
Wei, Ying, Luo, Qing-Li, Sun, Jing, Chen, Mei-Xia, Liu, Feng, and Dong, Jing-Cheng
- Subjects
- *
ASTHMA prevention , *LYMPHOCYTE metabolism , *LUNG analysis , *ALTERNATIVE medicine , *ANIMAL experimentation , *ANTI-inflammatory agents , *BASOPHILS , *BIOPHYSICS , *BRONCHOALVEOLAR lavage , *CYTOKINES , *ENZYME-linked immunosorbent assay , *EOSINOPHILS , *FLOW cytometry , *GROWTH factors , *HERBAL medicine , *HIGH performance liquid chromatography , *HISTOLOGICAL techniques , *INTERLEUKINS , *MASS spectrometry , *RESEARCH methodology , *CHINESE medicine , *MICE , *MONOCYTES , *NEUTROPHILS , *ORAL drug administration , *PROBABILITY theory , *SPLEEN , *STAINS & staining (Microscopy) , *T cells , *WESTERN immunoblotting , *STATISTICAL significance , *DESCRIPTIVE statistics , *PHARMACODYNAMICS - Abstract
Ethnopharmacological relevance Bu-Shen-Yi-Qi formulae (BSYQF) are frequently used in the treatment of chronic inflammatory diseases in the respiratory system in traditional Chinese medicine (TCM). However, the regulatory effect of BSYQF on T helper 17 (Th17) and regulatory T (Treg) cells in murine ovalbumin (OVA) asthma model remains poorly understood. In the present study, we sought to determine the effect of high-performance liquid chromatography/mass spectrometry (HPLC/MS) standardized BSYQF on chronic airway inflammation and Th17/Treg imbalance in the murine OVA asthma model. Materials and methods The murine asthma model was induced by OVA sensitization and challenge and BSYQF was oral administrated. 24 h after last OVA exposure, airway hyperresponsiveness (AHR) to methacholine (Mch) was assessed, and inflammatory cell counts and classification in bronchoalveolar lavage fluid (BALF) were analysed. Histopathological evaluation of the lung tissue was performed by hematoxylin and eosin (H&E) and periodic acid–Schiff (PAS) staining. Th17 and Treg associated cytokine levels in serum and BALF as well as transcription factors expression in the lung tissue were measured by ELISA, Bio-Plex and western blot assay. We also analysed the CD4 + RORγt + and CD4 + Foxp3 + T cells in BALF and spleen by flow cytometric analysis. Results Our results demonstrated that oral administration of BSYQF inhibited the markedly increased AHR and lung inflammation ( p <0.05), resulted in a dramatic reduction in total inflammatory cells as well as neutrophils (Neu), lymphocytes (Lym), monocytes (Mon), eosinophils (Eos) and basophils (Bas) of OVA-induced asthmatic mice ( p <0.05). Furthermore, BSYQF treatment caused a distinct reduction in IL-6, IL-10 and IL-17A levels in serum ( p <0.05), and induced a significant improvement in IL-6 and IL-10 as well as a marked decrease in TGF-β1 and IL-17A levels in BALF of OVA-induced asthmatic mice ( p <0.05). Mice in BSYQF treated groups also had decreased RORγt and increased Foxp3 expression in the lung tissue ( p <0.05). Flow cytometry analysis revealed that CD4 + RORγt + T cells elevated markedly and CD4 + Foxp3 + T cells decreased prominently in BALF and spleen in murine OVA asthma model ( p <0.05), and BSYQF and DEX treatment lead to an obvious reduction in CD4 + RORγt + T cells in BALF ( p <0.05) but not in spleen. BSYQF and DEX treatment resulted in an obvious elevation in CD4 + Foxp3 + T cells in BALF and spleen ( p <0.05). Conclusions Collectively, these results demonstrated that BSYQF could suppress chronic airway inflammation and regulate Th17/Treg imbalance by inhibition of Th17 and enhancement of Treg functions in the murine OVA asthma model, which may help to elucidate the underlying regulatory mode of BSYQF on asthma treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
6. Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis.
- Author
-
Kim, Kevin K, Wei, Ying, Szekeres, Charles, Kugler, Matthias C, Wolters, Paul J, Hill, Marla L, Frank, James A, Brumwell, Alexis N, Wheeler, Sarah E, Kreidberg, Jordan A, and Chapman, Harold A
- Subjects
- *
EMBRYONIC physiology , *ANIMALS , *ANTINEOPLASTIC antibiotics , *BLEOMYCIN , *CARRIER proteins , *CELL culture , *CELL receptors , *CELLULAR signal transduction , *CYTOSKELETAL proteins , *EPITHELIAL cells , *FIBROBLASTS , *LUNGS , *LUNG injuries , *MICE , *PULMONARY fibrosis , *PHENOTYPES , *EMBRYOS , *ACUTE diseases , *PHARMACODYNAMICS , *CELL physiology - Abstract
Pulmonary fibrosis, in particular idiopathic pulmonary fibrosis (IPF), results from aberrant wound healing and scarification. One population of fibroblasts involved in the fibrotic process is thought to originate from lung epithelial cells via epithelial-mesenchymal transition (EMT). Indeed, alveolar epithelial cells (AECs) undergo EMT in vivo during experimental fibrosis and ex vivo in response to TGF-beta1. As the ECM critically regulates AEC responses to TGF-beta1, we explored the role of the prominent epithelial integrin alpha3beta1 in experimental fibrosis by generating mice with lung epithelial cell-specific loss of alpha3 integrin expression. These mice had a normal acute response to bleomycin injury, but they exhibited markedly decreased accumulation of lung myofibroblasts and type I collagen and did not progress to fibrosis. Signaling through beta-catenin has been implicated in EMT; we found that in primary AECs, alpha3 integrin was required for beta-catenin phosphorylation at tyrosine residue 654 (Y654), formation of the pY654-beta-catenin/pSmad2 complex, and initiation of EMT, both in vitro and in vivo during the fibrotic phase following bleomycin injury. Finally, analysis of lung tissue from IPF patients revealed the presence of pY654-beta-catenin/pSmad2 complexes and showed accumulation of pY654-beta-catenin in myofibroblasts. These findings demonstrate epithelial integrin-dependent profibrotic crosstalk between beta-catenin and Smad signaling and support the hypothesis that EMT is an important contributor to pathologic fibrosis. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
7. Differential effects of sleep deprivation on behavior and microglia in a brain-region-specific manner in young and aged male mice.
- Author
-
Ni, Rong-Jun, Wang, Yi-Yan, Pu, Wen-Jun, Wei, Ying-Ying, Wei, Jin-Xue, Zhao, Lian-Sheng, and Ma, Xiao-Hong
- Subjects
- *
SLEEP , *SLEEP deprivation , *MICROGLIA , *CENTRAL nervous system , *MICE - Abstract
Our data demonstrated brain region-specific microglial heterogeneity in young and old mice. In addition, sleep deprivation (SD) disrupted microglia and behaviors in an age-specific manner. Microglial density in the brain is significantly positively correlated with SD-induced hyperactivity in young mice. Contrarily, negative correlations are shown between the microglial density and behaviors in vehicle-treated young and old mice. [Display omitted] • Brain region-specific microglial heterogeneity in young and old mice. • Sleep deprivation disrupts microglia and behaviors in an age-specific manner. • Microglial density is positively correlated with SD-induced behaviors in youngs. • Microglial density is negatively correlated with behaviors in young and old mice. Microglia, resident immune cells in the central nervous system, constantly monitor the state of the surrounding brain activity. The animal model induced by sleep deprivation (SD) is widely used to study the pathophysiological mechanisms of insomnia and bipolar disorder. However, it remains unclear whether SD affects behaviors in young and aged male mice and microglia in various brain regions. In this study, we confirmed brain region-specific changes in microglial density and morphology in the accumbens nucleus (Acb), amygdala (AMY), cerebellum (Cb), corpus callosum (cc), caudate putamen, hippocampus (HIP), hypothalamus (HYP), medial prefrontal cortex (mPFC), and thalamus (TH) of young mice. In addition, the density of microglia in old mice was higher than that in young mice. Compared with young mice, old mice showed a markedly increased microglial size, decreased total length of microglial processes, and decreased maximum length. Importantly, we found that 48-h SD decreased microglial density and morphology in old mice, whereas SD increased microglial density and morphology in most observed brain regions in young mice. SD-induced hyperactivity was observed only in young mice but not in old mice. Moreover, microglial density (HIP, AMY, mPFC, CPu) was significantly positively correlated with behaviors in SD- and vehicle-treated young mice. Contrarily, negative correlations were shown between the microglial density (cc, Cb, TH, HYP, Acb, AMY) and behaviors in vehicle-treated young and old mice. These results suggest that SD dysregulates the homeostatic state of microglia in a region- and age-dependent manner. Microglia may be involved in regulating age-related behavioral responses to SD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Hypoglycemic effects and biochemical mechanisms of Pea oligopeptide on high‐fat diet and streptozotocin‐induced diabetic mice.
- Author
-
Wei, Ying, Zhang, Ruixue, Fang, Lei, Qin, Xiuyuan, Cai, Muyi, Gu, Ruizeng, Lu, Jun, and Wang, Yuqing
- Subjects
- *
GLYCEMIC index , *OLIGOPEPTIDES , *HIGH-fat diet , *PEAS , *TYPE 2 diabetes , *BLOOD sugar , *MICE - Abstract
The aim of this study was to evaluate the hypoglycemic effects of Pea oligopeptide on the glycemic and lipidemic status of mice with type 2 diabetes (T2D) induced by a high‐fat diet and streptozotocin (STZ). Using HPLC‐MS/MS spectra processing, 70 significant peptide (2–3 amino acids) sequences were identified, noting four peptides from Pea oligopeptide with a proline residue at the C‐terminus, which might have dipeptidase‐IV (DPP‐IV) inhibitory activity for the treatment of T2D. After a 4‐week administration of Pea oligopeptide and metformin, various blood biochemical indexes and organic histopathologies were detected to aid the discussion regarding potential mechanisms. The results showed a significant reduction in the levels of blood glucose, lipid profiles, and liver fat deposition in diabetic mice. Furthermore, Pea oligopeptide and metformin improved glucose tolerance, promoted glycogen synthesis, and protected the liver and kidney structures in diabetic mice. The results indicated that Pea oligopeptide played an essential role in the hypoglycemic effect in the T2D mice model. Practical applications: This paper examined the preliminary hypoglycemic activities of Pea oligopeptide in a high‐fat diet and STZ‐induced T2D mice. Furthermore, four kinds of dipeptides and tripeptides that might exhibit antidiabetic functions were detected using HPLC‐MS/MS. The results provided practical knowledge regarding the hypoglycemic effects of Pea oligopeptide and established the foundation of its structure–function relationships. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
9. Annexin A1‐derived peptide Ac2‐26 facilitates wound healing in diabetic mice.
- Author
-
Huang, Jun‐Jie, Xia, Chong‐Jian, Wei, Ying, Yao, Yi, Dong, Miao‐Wu, Lin, Ke‐Zhi, Yu, Lin‐Sheng, Gao, Yuan, and Fan, Yan‐Yan
- Subjects
- *
DIABETES complications , *ANIMAL experimentation , *BIOLOGICAL models , *CALCIUM-binding proteins , *COLLAGEN , *CYTOKINES , *DIABETES , *IMMUNOBLOTTING , *IMMUNOHISTOCHEMISTRY , *INTERLEUKINS , *MACROPHAGES , *MICE , *NEUTROPHILS , *STAINS & staining (Microscopy) , *TUMOR necrosis factors , *WOUND healing , *TRAUMATOLOGY diagnosis , *VASCULAR endothelial growth factors , *PATTERN perception receptors - Abstract
Impaired wound healing is a common complication of diabetes. In diabetic wounds, macrophages present dysfunctional efferocytosis and abnormal phenotypes, which could result in excessive neutrophil accumulation and prolonged inflammation, thereby eventually hindering wound repair. ANXA1 N‐terminal peptide Ac2‐26 exhibits a high potential in mitigating inflammation and improving repair; however, its efficacy in diabetic wound repair remains unclear. In this study, a cutaneous excisional wound model was built in genetically diabetic mice. Ac2‐26 or a vehicle solution was employed locally in wound sites. Subsequently, wound zones were measured and sampled at different time intervals post‐wounding. Using hematoxylin‐eosin and Masson's trichrome staining, we observed the histopathological variations and collagen deposition in wound samples. Based on immunohistochemistry and immunofluorescence, the numbers of neutrophils, macrophages, and CD206‐positive macrophages in the wound samples were determined. Cytokine expression in wound samples was studied by immunoblot assay. Results showed that Ac2‐26 treatment could facilitate diabetic wound closure, down‐regulate the number of neutrophils, and improve angiogenesis and collagen deposition. In addition, Ac2‐26 application expedited macrophage recruitment and up‐regulated the percentage of macrophages expressing CD206, which is a marker for M2 macrophages. Moreover, Ac2‐26 inhibited the expressions of TNF‐α and IL‐6 and up‐regulated the expressions of IL‐10, TGF‐β, and VEGFA during diabetic wound healing. Hence, based on the aforementioned findings, Ac2‐26 application in diabetic wounds could exert anti‐inflammatory and pro‐repair effects by reducing neutrophil accumulation and facilitating M2 macrophage development. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
10. Protective effects of Qing-Re-Huo-Xue formula on bleomycin-induced pulmonary fibrosis through the p53/IGFBP3 pathway.
- Author
-
Yang, Fangyong, Du, Wenjing, Tang, Zhao, Wei, Ying, and Dong, Jingcheng
- Subjects
- *
BIOLOGICAL models , *BIOCHEMISTRY , *IDIOPATHIC pulmonary fibrosis , *HERBAL medicine , *PULMONARY surfactant , *IN vivo studies , *ANIMAL experimentation , *IMMUNOHISTOCHEMISTRY , *PHENOMENOLOGICAL biology , *ONCOGENES , *CELL physiology , *CELLULAR signal transduction , *DIAGNOSTIC imaging , *ELECTRON microscopy , *GENE expression , *PROTEOMICS , *TREATMENT effectiveness , *PULMONARY function tests , *RESEARCH funding , *MESSENGER RNA , *BLEOMYCIN , *POLYMERASE chain reaction , *CHINESE medicine , *MICE , *CARRIER proteins , *DRUG administration , *DRUG dosage , *THERAPEUTICS - Abstract
Background: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing lung disease with high mortality. Inflammation and epithelial mesenchymal transformation (EMT) may play an important role in the occurrence and development of IPF. Qing-Re-Huo-Xue formula (QRHXF) has been used clinically by our team for half a century and has obvious therapeutic effects on lung disease. Nevertheless, the role and mechanism of QRHXF in the treatment of IPF have never been studied. Methods: A mouse pulmonary fibrosis model was established by intratracheal injection of BLM. The effects of QRHXF on the treatment of pulmonary fibrosis were studied by pulmonary function testing, imaging examination, pathological staining, transmission electron microscopy (TEM) observation and mRNA expression. Tandem mass tag (TMT)-based quantitative proteomics was carried out to analyse the lung protein expression profiles between the control (CTL), bleomycin (BLM) and QRHXF (BLM + QRHXF) groups. Immunohistochemistry and qRT-PCR were used to verify the possible existence of drug target proteins and signalling pathways. Results: The results of pulmonary function, lung pathology and imaging examinations showed that QRHXF could significantly alleviate BLM-induced pulmonary fibrosis in vivo. Additionally, inflammatory cell infiltration and EMT were markedly reduced in BLM-induced PF mice administered QRHXF. Proteomics detected a total of 35 proteins, of which 17 were upregulated and 18 were downregulated. A total of 19 differentially expressed proteins (DEPs) overlapped between the BLM versus CTL groups and the BLM + QRHXF versus BLM groups. The expression of p53 and IGFBP3 was reversed in the QRHXF intervention group, which was verified by immunohistochemistry and qRT-PCR. Conclusions: QRHXF attenuated BLM-induced pulmonary fibrosis, and regulation of the p53/IGFBP3 pathway might be associated with its efficacy, which holds promise as a novel treatment strategy for pulmonary fibrosis patients. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
11. Paeoniflorin combined with norfloxacin ameliorates drug-resistant Streptococcus suis infection.
- Author
-
Li, Jinpeng, Fan, Qingying, Zuo, Jing, Xue, Bingqian, Zhang, Xiaoling, Wei, Ying, Sun, Liyun, Grenier, Daniel, Yi, Li, Hou, Xiaogai, and Wang, Yang
- Subjects
- *
ANTIBIOTICS , *BACTERIAL proteins , *BIOFILMS , *RESEARCH funding , *HYDROCARBONS , *ANIMALS , *STREPTOCOCCUS , *ANTI-infective agents , *NORFLOXACIN , *QUINOLONE antibacterial agents , *MICE , *GLYCOSIDES , *IMPACT of Event Scale , *PHARMACODYNAMICS - Abstract
Background: The increased resistance of bacterial pathogens to fluoroquinolones (FQs), such as norfloxacin and ciprofloxacin, supports the need to develop new antibacterial drugs and combination therapies using conventional antibiotics. The LuxS/AI-2 quorum sensing (QS) system can regulate the complex group behaviour of Streptococcus suis and impact its susceptibility to FQs.Objectives: We investigated the combination of paeoniflorin and norfloxacin as a novel and effective strategy against FQ-resistant S. suis.Methods: FIC, AI-2 activity assay, real-time RT-PCR and biofilm inhibition assays were performed to investigate the in vitro effect of paeoniflorin combined with norfloxacin. Mouse protection and mouse anti-infection assays were performed to investigate the in vivo effect of paeoniflorin combined with norfloxacin.Results: FIC results showed that paeoniflorin and norfloxacin exert a synergistic bactericidal effect. Evidence was brought that paeoniflorin reduces the S. suis AI-2 activity and significantly down-regulates the transcription of the FQ efflux pump gene. In addition, paeoniflorin can inhibit biofilm formation, thereby promoting the ability of norfloxacin to kill S. suis. Finally, we showed in a mouse model that paeoniflorin in association with norfloxacin is effective to treat S. suis infections.Conclusions: This study highlighted the inhibitory potential of paeoniflorin on the LuxS/AI-2 QS system of S. suis, and provided evidence that it can inhibit the FQ efflux pump and prevent biofilm formation to cooperate with norfloxacin in the treatment of resistant S. suis-related infections. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
12. The Gut Microbial Co-Abundance Gene Groups (CAGs) Differentially Respond to the Flavor (Yao-Wei) of Chinese Materia Medica.
- Author
-
Yang, Ya-Nan, Deng, Yu-Ting, Zang, Chen-Chen, Zhang, Fang, Huang, Zi-Bao, Dong, Lin, Lu, Wei-Ying, Zhang, Xiao-Po, and Wu, Chong-Ming
- Subjects
- *
FLAVORING essences , *RESEARCH , *GUT microbiome , *ANIMAL experimentation , *RNA , *QUANTITATIVE research , *HOMEOPATHIC agents , *BIOINFORMATICS , *GENES , *RESEARCH funding , *PLANT extracts , *DATA analysis software , *STATISTICAL correlation , *CHINESE medicine , *MICE - Abstract
The property theory is a unique principle instructing traditional Chinese doctors to prescribe proper medicines against diseases. As an essential part of it, the five-flavor theory catalogs various Chinese materia medicas (CMMs) into five flavors (sweet, bitter, sour, salty, and pungent) based on their taste and medical functions. Although CMM has been successfully applied in China for thousands of years, it is still a big challenge to interpret CMM flavor via modern biomarkers, further deepening its elusiveness. Herein, to identify the correlation between gut microbiota and CMM flavor, we selected 14 CMMs with different flavors to prepare their aqueous extracts, quantified the contained major chemical components, and then performed full-length 16S rRNA sequencing to analyze the gut microbiota of C57BL/6 mice administrated with CMM extracts. We found that flavones, alkaloids, and saponins were the richest components for sweet-, bitter-, and pungent-flavored CMMs, respectively. Medicines with merged flavors (bitter-pungent and sweet-pungent) displayed mixed profiles of components. According to gut microbial analysis, modulation of CMMs belonging to the same flavor on the taxonomic classification was inconsistent to an extent, while the functional sets of gut microbiota, co-abundance gene groups (CAGs), strongly and differentially responded to distinct flavors. Moreover, these correlations were in line with their pharmacological actions. Therefore, the gut microbial functional sets (CAGs) could act as the possible indicator to reflect CMM flavor, rather than the composition of microbial community. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
13. GLP-2 ameliorates D-galactose induced muscle aging by IGF-1/Pi3k/Akt/FoxO3a signaling pathway in C2C12 cells and mice.
- Author
-
Ye, Yang-Li, Kuai, Zheng, Qian, Dian-Dian, He, Yu-Ting, Shen, Ji-Ping, Wu, Ke-Fen, Ren, Wei-Ying, and Hu, Yu
- Subjects
- *
PROTEINS , *IN vitro studies , *SKELETAL muscle , *PHOSPHORYLATION , *APOPTOSIS , *CELLULAR signal transduction , *IN vivo studies , *FLUORESCENT antibody technique , *GLUCAGON-like peptides , *CELL lines , *MICE , *GENE expression , *AGING , *ANIMAL experimentation , *HISTOLOGICAL techniques , *WESTERN immunoblotting , *STAINS & staining (Microscopy) , *GRIP strength - Abstract
• GLP-2 ameliorated D-galactose induced muscle atrophy in mice. • GLP-2 promoted protein synthesis and alleviated protein degradation and apoptosis. • The IGF-1/PI3K/Akt/FoxO3 pathway played a role in the protective effect of GLP-2. The study aimed to investigate the effect of Glucagon-like peptide-2 (GLP-2) on muscle aging in vivo and in vitro. Six-week-old C57BL/6J mice were administered with D-galactose (200 mg/kg/day, intraperitoneally) for 8weeks, followed by daily subcutaneous injections of GLP-2 (300 or 600 μg/kg/day) for 4weeks. Skeletal muscle function and mass were evaluated using relative grip strength and muscle weight. The sizes and types of muscle fibers and apoptosis were assessed through histological analysis, immunofluorescence staining, and TUNEL staining, respectively. C2C12 myotubes were treated with D-galactose (40 mg/mL) and GLP-2. Protein expression of differentiation-related myogenic differentiation factor D (MyoD), myogenin (MyoG), and myosin heavy chain (Myhc), degradation-related Muscle RING finger 1 (MuRF-1), and muscle atrophy F-box (MAFbx)/Atrogin-1, and apoptosis-related B-cell leukemia/lymphoma 2 (Bcl-2) and Bax, were assessed using western blots. The Pi3k inhibitor LY294002 was applied to investigate whether GLP-2 regulated myogenesis and myotube aging via IGF-1/Pi3k/Akt/FoxO3a signaling pathway. The results demonstrated that GLP-2 significantly reversed the decline in muscles weight, relative grip strength, diameter, and cross-sectional area of muscle fibers induced by D-galactose in mice. Apart from suppressing the expressions of MuRF-1 and Atrogin-1 in the muscles and C2C12 myotubes, GLP-2 significantly increased the expressions of MyoD, MyoG, and Myhc compared to the D-galactose. GLP-2 significantly suppressed cell apoptosis. Western blot analysis indicated that the regulation of GLP-2 may be attributed to the activation of theIGF-1/Pi3k/Akt/FoxO3a phosphorylation pathway. This study suggested that GLP-2 ameliorated D-galactose induced muscle aging by IGF-1/Pi3k/Akt/FoxO3a pathway. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Icariside Ⅱ attenuates bleomycin-induced pulmonary fibrosis by modulating macrophage polarization.
- Author
-
Deng, Lingling, Ouyang, Boshu, Shi, Hanlin, Yang, Fangyong, Li, Shihuan, Xie, Cong, Du, Wenjing, Hu, Lingli, Wei, Ying, and Dong, Jingcheng
- Subjects
- *
DRUG efficacy , *IN vitro studies , *TRANSFORMING growth factors-beta , *REVERSE transcriptase polymerase chain reaction , *FLOW cytometry , *COLLAGEN , *INTERLEUKINS , *FLAVONOIDS , *MEDICINAL plants , *HERBAL medicine , *BRONCHOALVEOLAR lavage , *SEQUENCE analysis , *ANTI-inflammatory agents , *ANIMAL experimentation , *WESTERN immunoblotting , *LUNGS , *FIBROSIS , *GLYCOSIDES , *MACROPHAGES , *TREATMENT effectiveness , *CELLULAR signal transduction , *FLUORESCENT antibody technique , *GENE expression profiling , *TUMOR necrosis factors , *BLEOMYCIN , *PULMONARY fibrosis , *PLANT extracts , *CELL lines , *MICE , *CHINESE medicine , *PLATELET-derived growth factor , *PHENOTYPES , *PHARMACODYNAMICS - Abstract
Numerous studies have provided evidence supporting the significant roles of icariin, in the prevention of multiple chronic diseases like diabetes, liver fibrosis, cardiac fibrosis, renal fibrosis, and pulmonary fibrosis. In particular, Icariside II (ISE II), a prominent flavonoid glycoside derived from Epimedium brevicornum Maxim , the principal metabolite of icariin, has demonstrated noteworthy anti-inflammatory and anti-oxidant properties, along with its ability to protect against lung remodeling. However, the research exploring ISE Ⅱ's application in treating pulmonary fibrosis remains limited. The aim of this study was to assess the therapeutic efficacy of ISE II in models of pulmonary fibrosis, while also investigating its potential mechanisms of action in cell signaling pathways. An in vitro model of pulmonary fibrosis was established by treating NIH-3T3 cells with transforming growth factor-β1 (TGF-β1). Western blot, RT-qPCR, and scratch test were performed to assess the effect of ISE Ⅱ. In addition, a murine model of pulmonary fibrosis was induced by intratracheal instillation of bleomycin, and the therapeutic effect of ISE Ⅱ was tested by orally administering ISE Ⅱ at a dose of 10 mg/kg. Three weeks later, lung function, micro-CT, hydroxyproline content, pathological staining, and cytokines detection of BALF or serum were used to assess the anti-fibrosis effects of ISE Ⅱ. Next, immunofluorescence staining, flow cytometry, and in vivo transcriptomics were used to investigate the underlying mechanisms of action. Our data revealed a significant inhibitory effect of ISE Ⅱ on the upregulation of α-smooth muscle actin (α-SMA) and collagen production induced by TGF-β1 in fibroblasts. Meanwhile, ISE Ⅱ exerted a therapeutic effect against bleomycin-induced pulmonary fibrosis in mice by improving lung function, decreasing collagen deposition, and reducing the expression of interleukin (IL)-1β, tumor necrosis factor α (TNF-α), TGF-β1 and platelet-derived growth factor (PDGF) in serum and bronchoalveolar lavage fluid (BALF). Additionally, ISE Ⅱ treatment effectively attenuated the infiltration of M2 macrophages, concurrently downregulating the expression level of M2 marker genes, such as CD206, arginase-1(Arg-1), and Chitinase-Like Protein 3 (YM-1). Importantly, we observed a statistically significant reduction in the M2 phenotype of interstitial macrophages (IMs). However, the impact of ISE Ⅱ on the M2 polarization of alveolar macrophages (AMs) did not reach statistical significance. Lastly, transcriptome sequencing results suggested that the anti-pulmonary fibrosis effects of ISE Ⅱ may be mediated by the suppression of the WNT/β-catenin signaling pathway, which modulated M2 polarization in macrophages and contributed to the amelioration of pulmonary fibrosis. By immunohistochemical analysis, it was verified that ISE Ⅱ treatment dramatically inhibited the activation of β-catenin in fibrosis murine. Our findings indicated that ISE Ⅱ exerted anti-fibrotic effects by inhibiting pro-fibrotic macrophage polarization. The underlying mechanism of action might be mediated by modulating the WNT/β-catenin signaling pathway to inhibit the M2 program in IMs. [Display omitted] • To our knowledge, this is the first study to estimate the anti-pulmonary fibrosis for ISE II in vitro and in vivo. • ISE II improved pulmonary function and reduced fibrotic biomarkers in a murine model of bleomycin-induced lung fibrosis. • ISE Ⅱ suppressed the infiltration of CD206+ M2-like interstitial macrophages. • Transcriptome sequencing suggested ISE Ⅱ might involve inhibiting the WNT/β-catenin signaling pathway. • This study might yield new insights into ISE II's potential for treating respiratory illnesses. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
15. RNA-Seq Expression Analysis of Chronic Asthmatic Mice with Bu-Shen-Yi-Qi Formula Treatment and Prediction of Regulated Gene Targets of Anti-Airway Remodeling.
- Author
-
Cui, Jie, Lv, Zexi, Teng, Fangzhou, Yi, La, Tang, Weifeng, Wang, WenQian, Tulake, Wuniqiemu, Qin, Jingjing, Zhu, Xueyi, Wei, Ying, and Dong, Jingcheng
- Subjects
- *
ASTHMA treatment , *RNA analysis , *ANIMAL experimentation , *CELLULAR signal transduction , *GENE expression , *HERBAL medicine , *CHINESE medicine , *MICE , *MITOCHONDRIA , *POLYMERASE chain reaction , *OXIDATIVE stress , *SEQUENCE analysis , *THERAPEUTICS - Abstract
Airway remodeling is one of the typical pathological characteristics of asthma, while the structural changes of the airways in asthma are complex, which impedes the development of novel asthma targeted therapy. Our previous study had shown that Bu-Shen-Yi-Qi formula (BSYQF) could ameliorate airway remodeling in chronic asthmatic mice by modulating airway inflammation and oxidative stress in the lung. In this study, we analysed the lung transcriptome of control mice and asthmatic mouse model with/without BSYQF treatment. Using RNA-sequencing (RNA-seq) analysis, we found that 264/1746 (15.1%) of transcripts showing abnormal expression in asthmatic mice were reverted back to completely or partially normal levels by BSYQF treatment. Additionally, based on previous results, we identified 21 differential expression genes (DEGs) with fold changes (FC) > (±) 2.0 related to inflammatory, oxidative stress, mitochondria, PI3K/AKT, and MAPK signal pathways which may play important roles in the mechanism of the anti-remodeling effect of BSYQF treatment. Through inputting 21 DEGs into the IPA database to construct a gene network, we inferred Adipoq, SPP1, and TNC which were located at critical nodes in the network may be key regulators of BSYQF's anti-remodeling effect. In addition, the quantitative real-time polymerase chain reaction (qRT-PCR) result for the selected four DEGs matched those of the RNA-seq analysis. Our results provide a preliminary clue to the molecular mechanism of the anti-remodeling effect of BSYQF in asthma. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
16. Microbiota-Produced -Formyl Peptide fMLF Promotes Obesity-Induced Glucose Intolerance.
- Author
-
Wollam, Joshua, Riopel, Matthew, Yong-Jiang Xu, Johnson, Andrew M. F., Ofrecio, Jachelle M., Wei Ying, El Ouarrat, Dalila, Chan, Luisa S., Han, Andrew W., Mahmood, Nadir A., Ryan, Caitlin N., Yun Sok Lee, Watrous, Jeramie D., Chordia, Mahendra D., Pan, Dongfeng, Jain, Mohit, Olefsky, Jerrold M., Xu, Yong-Jiang, Ying, Wei, and Lee, Yun Sok
- Subjects
- *
GLUCOSE intolerance , *GLUCAGON-like peptide 1 , *ENTEROENDOCRINE cells , *GUT microbiome , *PEPTIDE receptors , *METABOLIC disorders , *ANIMAL experimentation , *CELL culture , *CELL physiology , *COMPARATIVE studies , *ANIMAL nutrition , *ENZYME-linked immunosorbent assay , *FLOW cytometry , *GLUCOSE , *INSULIN , *LIQUID chromatography , *MASS spectrometry , *RESEARCH methodology , *MEDICAL cooperation , *MICE , *OBESITY , *OLIGOPEPTIDES , *RESEARCH , *FLUORESCENCE in situ hybridization , *EVALUATION research - Abstract
The composition of the gastrointestinal microbiota and associated metabolites changes dramatically with diet and the development of obesity. Although many correlations have been described, specific mechanistic links between these changes and glucose homeostasis remain to be defined. Here we show that blood and intestinal levels of the microbiota-produced N-formyl peptide, formyl-methionyl-leucyl-phenylalanine, are elevated in high-fat diet-induced obese mice. Genetic or pharmacological inhibition of the N-formyl peptide receptor Fpr1 leads to increased insulin levels and improved glucose tolerance, dependent upon glucagon-like peptide 1. Obese Fpr1 knockout mice also display an altered microbiome, exemplifying the dynamic relationship between host metabolism and microbiota. Overall, we describe a new mechanism by which the gut microbiota can modulate glucose metabolism, providing a potential approach for the treatment of metabolic disease. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
17. Fibroblast-specific inhibition of TGF-β1 signaling attenuates lung and tumor fibrosis.
- Author
-
Ying Wei, Kim, Thomas J., Peng, David H., Duan, Dana, Gibbons, Don L., Mitsuo Yamauchi, Jackson, Julia R., Le Saux, Claude J., Calhoun, Cheresa, Peters, Jay, Derynck, Rik, Backes, Bradley J., Chapman, Harold A., Wei, Ying, and Yamauchi, Mitsuo
- Subjects
- *
FIBROBLASTS , *COLLAGEN diseases , *CELL proliferation , *EPITHELIAL cells , *CYTOKINES , *PROTEIN metabolism , *ANIMAL experimentation , *ANIMALS , *ANTINEOPLASTIC agents , *CELL receptors , *CELLULAR signal transduction , *CLINICAL drug trials , *ENZYME inhibitors , *GROWTH factors , *LUNG tumors , *METASTASIS , *MICE , *MOLECULAR structure , *OXIDOREDUCTASES , *PHENOLS , *PROTEINS , *PULMONARY fibrosis , *RESEARCH funding , *TRANSFERASES , *PROTEIN kinase inhibitors , *CHEMICAL inhibitors , *PHARMACODYNAMICS - Abstract
TGF-β1 signaling is a critical driver of collagen accumulation and fibrotic disease but also a vital suppressor of inflammation and epithelial cell proliferation. The nature of this multifunctional cytokine has limited the development of global TGF-β1 signaling inhibitors as therapeutic agents. We conducted phenotypic screens for small molecules that inhibit TGF-β1-induced epithelial-mesenchymal transition without immediate TGF-β1 receptor (TβR) kinase inhibition. We identified trihydroxyphenolic compounds as potent blockers of TGF-β1 responses (IC50 ~50 nM), Snail1 expression, and collagen deposition in vivo in models of pulmonary fibrosis and collagen-dependent lung cancer metastasis. Remarkably, the functional effects of trihydroxyphenolics required the presence of active lysyl oxidase-like 2 (LOXL2), thereby limiting effects to fibroblasts or cancer cells, the major LOXL2 producers. Mechanistic studies revealed that trihydroxyphenolics induce auto-oxidation of a LOXL2/3-specific lysine (K731) in a time-dependent reaction that irreversibly inhibits LOXL2 and converts the trihydrophenolic to a previously undescribed metabolite that directly inhibits TβRI kinase. Combined inhibition of LOXL2 and TβRI activities by trihydrophenolics resulted in potent blockade of pathological collagen accumulation in vivo without the toxicities associated with global inhibitors. These findings elucidate a therapeutic approach to attenuate fibrosis and the disease-promoting effects of tissue stiffness by specifically targeting TβRI kinase in LOXL2-expressing cells. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
18. Targeting Tumor Microenvironment: Effects of Chinese Herbal Formulae on Macrophage-Mediated Lung Cancer in Mice.
- Author
-
Xu, Fei, Cui, Wenqiang, Zhao, Zhengxiao, Gong, Weiyi, Wei, Ying, Liu, Jiaqi, Li, Mihui, Li, Qiuping, Yan, Chen, Qiu, Jian, Liu, Baojun, and Dong, Jingcheng
- Subjects
- *
ANIMAL experimentation , *ANTINEOPLASTIC agents , *HERBAL medicine , *LUNG tumors , *RESEARCH methodology , *CHINESE medicine , *MICE - Abstract
Our previous studies have shown that Qing-Re-Huo-Xue (QRHX) formulae had significant anti-inflammatory effects in chronic airway diseases such as asthma and chronic obstructive lung disease. Here, we examined the effects of QRHX on lung cancer cell invasion and the potential associated mechanism(s), mainly polarization of macrophages in the tumor microenvironment. In vivo, QRHX both inhibited tumor growth and decreased the number of tumor-associated macrophages (TAMs) in mice with lung cancer. Further study indicated that QRHX inhibited cancer-related inflammation in tumor by decreasing infiltration of TAMs and IL-6 and TNF-α production and meanwhile decreased arginase 1 (Arg-1) expression and increased inducible NO synthase (iNOS) expression. QRHX could markedly inhibit CD31 and VEGF protein expression. Additionally, CXCL12/CXCR4 expression and JAK2/STAT3 phosphorylation were reduced in QRHX treatment group. Thus, we draw that QRHX played a more important role in inhibiting tumor growth by regulating TAMs in mice, which was found to be associated with the inhibition of inflammation and the CXCL12/CXCR4/JAK2/STAT3 signaling pathway. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
19. Effects of a Chinese traditional formula Kai Xin San (KXS) on chronic fatigue syndrome mice induced by forced wheel running
- Author
-
Cao, Yin, Hu, Yuan, Liu, Ping, Zhao, Hai-Xia, Zhou, Xiao-Jiang, and Wei, Ying-Mei
- Subjects
- *
CHRONIC fatigue syndrome , *BLOOD testing , *LIVER analysis , *ALTERNATIVE medicine , *ANALYSIS of variance , *ANIMAL experimentation , *BIOLOGICAL assay , *BIOLOGICAL models , *BIOPHYSICS , *COMPARATIVE studies , *ENZYME-linked immunosorbent assay , *GLYCOGEN , *HISTOLOGICAL techniques , *INTERLEUKINS , *KIDNEY function tests , *LACTATE dehydrogenase , *LACTIC acid , *RESEARCH methodology , *MEDICINAL plants , *BOTANIC medicine , *CHINESE medicine , *MICE , *STATISTICAL sampling , *TESTOSTERONE , *SKELETAL muscle , *PREVENTION - Abstract
Abstract: Ethnopharmacological relevance: In traditional medicine, Kai Xin San (KXS), composed of ginseng (Panax ginseng), hoelen (Wolfiporia cocos), polygala (Polygala tenuifolia) and Acorus gramineus, is famous for the treatment of emotion-thought disease, such as settling fright, quieting the spirit and nourishing the heart. Aim of the study: The present study investigated the effect of KXS on chronic fatigue syndrome (CFS) mice induced by forced wheel running. Materials and methods: Seventy two healthy adult male Kunming mice were randomly divided into six groups: home cage control group, CFS group, CFS group with Modafinil treatment at 13mg/kg/d doge, KXS treatment at 175mg/kg/d, 350mg/kg/d and 700mg/kg/d doge. CFS mice were induced by forced wheel running with higher speed for 4 weeks and then taken an exhausted exercise. The biochemical parameters including serum lactate dehydrogenase (LDH), serum urea nitrogen (SUN), serum testosterone (T), liver glycogen (LG), muscle glycogen (MG) and muscle lactic acid (MLA) were determined by using commercially available kits. The splenocytes proliferation from mice was examined by MTT method. The levels of interleukin-2 (IL-2) and interleukin-4 (IL-4) secreted by splenocytes were determined by ELISA. Results: CFS mice with KXS administration exhibited less electric shock time when compared with CFS group without drug treatment. The effect of KXS has after demonstrated reduction in SUN, LDH and MLA levels and an increase in T, LG and MG levels. CFS mice with KXS could improve the proliferation of splenocytes compared with CFS group without drug treatment. The cultured splenocytes from CFS mice without KXS supplementation produced more interleukin-2 (IL-2) but less interleukin-4 (IL-4) when compared with home cage control mice. The cultured splenocytes of CFS mice with KXS supplementation produced more interleukin-2 (IL-2) but less interleukin-4 (IL-4) when compared with CFS group without drug treatment. Conclusions: The results of this preliminary study provide evidence that KXS could ameliorate CFS by affecting the physiological markers for fatigue. This study also supported the use of KXS against CFS by improving the proliferation of splenocytes from CFS mice and modulating the disturbance of cytokines induced by CFS. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
20. Integrin α6β4 identifies an adult distal lung epithelial population with regenerative potential in mice.
- Author
-
Chapman, Harold A., Xiaopeng Li, Alexander, Jonathan P., Brumwell, Alexis, Lorizio, Walter, Tan, Kevin, Sonnenberg, Arnoud, Ying Wei, Vu, Thiennu H., Li, Xiaopeng, and Wei, Ying
- Subjects
- *
EPITHELIAL cells , *CELL populations , *LABORATORY mice , *CELL differentiation , *BLEOMYCIN , *LUNG injuries , *LUNG physiology , *LUNG anatomy , *ANIMAL experimentation , *ANTINEOPLASTIC antibiotics , *CELL culture , *CELL receptors , *COMPARATIVE studies , *GLYCOPROTEINS , *LUNGS , *RESEARCH methodology , *MEDICAL cooperation , *MICE , *PULMONARY alveoli , *PULMONARY surfactant , *REGENERATION (Biology) , *RESEARCH , *RESPIRATORY mucosa , *EVALUATION research , *STEM cells , *PHARMACODYNAMICS , *PHYSIOLOGY , *CELL physiology - Abstract
Laminins and their integrin receptors are implicated in epithelial cell differentiation and progenitor cell maintenance. We report here that a previously unrecognized subpopulation of mouse alveolar epithelial cells (AECs) expressing the laminin receptor α6β4, but little or no pro-surfactant C (pro-SPC), is endowed with regenerative potential. Ex vivo, this subpopulation expanded clonally as progenitors but also differentiated toward mature cell types. Integrin β4 itself was not required for AEC proliferation or differentiation. An in vivo embryonic lung organoid assay, which we believe to be novel, was used to show that purified β4+ adult AECs admixed with E14.5 lung single-cell suspensions and implanted under kidney capsules self-organized into distinct Clara cell 10-kDa secretory protein (CC10+) airway-like and SPC+ saccular structures within 6 days. Using a bleomycin model of lung injury and an SPC-driven inducible cre to fate-map AECs, we found the majority of type II AECs in fibrotic areas were not derived from preexisting type II AECs, demonstrating that SPC- progenitor cells replenished type II AECs during repair. Our findings support the idea that there is a stable AEC progenitor population in the adult lung, provide in vivo evidence of AEC progenitor cell differentiation after parenchymal injury, and identify a strong candidate progenitor cell for maintenance of type II AECs during lung repair. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
21. Quantitative proteomic profiling of targeted proteins associated with Loki Zupa Decoction Treatment in OVA-Induced asthmatic mice.
- Author
-
Wuniqiemu, Tulake, Qin, Jingjing, Teng, Fangzhou, Nabijan, Mohammadtursun, Cui, Jie, Yi, La, Tang, Weifeng, Zhu, Xueyi, Abduwaki, Muhammadjan, Nurahmat, Mammat, Wei, Ying, and Dong, Jing cheng
- Subjects
- *
PROTEIN metabolism , *DRUG therapy for asthma , *ANIMAL experimentation , *ANTI-inflammatory agents , *CONNECTIVE tissues , *HERBAL medicine , *INFLAMMATION , *INFLAMMATORY mediators , *LUNG diseases , *MASS spectrometry , *CHINESE medicine , *MICE , *PROTEOMICS , *GENE expression profiling , *DRUG administration , *DRUG dosage , *PHARMACODYNAMICS - Abstract
Loki Zupa (LKZP) decoction is one of the herbal prescriptions in traditional Uyghur medicine, which is commonly used for treating airway abnormality. However, underlying pathological mechanism and pathways involved has not been well studied. In this paper, we aim to further confirmed the anti-inflammatory and anti-fibrotic role of LKZP decoction in airway, and uncover the passible mechanism involved via comprehensive quantitative proteomic DIA-MS analysis. Mice asthmatic model was established with sensitizing and challenging with OVA. Lung function, pathological status, and inflammatory cytokines were assessed. Total of nine lung tissues were analyzed using proteomic DIA-MS analysis and 18 lung tissues were subjected to PRM validation. Total of 704 differentially expressed proteins (DEPs) (363 up regulated, 341 down regulated) were quantified in comparison of asthmatic and healthy mice, while 152 DEPs (91 up regulated, 61 down regulated) were quantified in LKZP decoction treated compared to asthmatic mice. Total of 21 proteins were overlapped between three groups. ECM-receptor interaction was significantly enriched and commonly shared between downregulated DEPs in asthma and upregulated DEPs in LKZP decoction treated mice. Total of 20 proteins were subjected to parallel reaction monitoring (PRM) analysis and 16 of which were quantified. At last, two proteins, RMB 10 and COL6A6, were validated with significant difference (P < 0.001) in protein abundance. Conclusions : Our results suggest that attenuated airway inflammation and fibrosis caused by LKZP decoction may associated with ECM-receptor interaction and RMB 10 and COL6A6 may be targeted by LKZP decoction in OVA-induced asthmatic mice. Image 1 [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.